- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Shoulder Innovations erhält FDA-Zulassung für Titanimplantat und startet Markteinführung | 2 | Investing.com Deutsch | ||
| Do | Shoulder Innovations receives FDA clearance for titanium implant | 1 | Investing.com | ||
| Do | Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch | 92 | PR Newswire | Second Product Introduction on New Line of Technologies for Metal-Sensitive Patients
GRAND RAPIDS, Mich., Sept. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc.... ► Artikel lesen | |
| Mi | Shoulder Innovations partners with ALM Ortho on implants | 3 | Investing.com | ||
| 12.08. | Shoulder Innovations auf Canaccord Genuity Konferenz: Wachstum beschleunigt, Margen steigen | 1 | Investing.com Deutsch | ||
| 10.08. | SHOULDER INNOVATIONS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| SHOULDER INNOVATIONS Aktie jetzt für 0€ handeln | |||||
| 10.08. | Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer | 181 | PR Newswire | GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology... ► Artikel lesen | |
| 07.08. | Shoulder Innovations, Inc. GAAP EPS of -$0.49 misses by $0.03, revenue of $17.2M beats by $0.63M | 1 | Seeking Alpha | ||
| 07.08. | Shoulder Innovations projects $67M-$69M 2026 net revenue as InSet Neo targets FDA submission in H1 2027 | 1 | Seeking Alpha | ||
| 06.08. | Earnings Call: Shoulder Innovations steigert Umsatz um 56 % im 2. Quartal 2026 | 2 | Investing.com Deutsch | ||
| 06.08. | SHOULDER INNOVATIONS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 06.08. | Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook | 112 | PR Newswire | Generates First Half 2026 Revenue Growth of 60%
GRAND RAPIDS, Mich., Aug. 6, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company)... ► Artikel lesen | |
| 29.07. | Biotech Stocks At 52-Week Highs - Incyte Rises With Q2 Results, Pulse Biosciences, Shoulder Innovations, Bioventus, LB Pharmaceuticals | 804 | AFX News | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 28, 2026, driven by key catalysts including positive quarterly results.Incyte Corporation (INCY)Incyte is a... ► Artikel lesen | |
| 29.06. | Shoulder Innovations closes $50M credit facility refinancing | 2 | Investing.com | ||
| 26.06. | SHOULDER INNOVATIONS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.05. | Wall Street Analysts Think Shoulder Innovations, Inc. (SI) Could Surge 35.96%: Read This Before Placing a Bet | 2 | Zacks | ||
| 14.05. | Piper Sandler reiterates Overweight on Shoulder Innovations stock | 4 | Investing.com | ||
| 14.05. | Shoulder Innovations forecasts $65M-$68M 2026 net revenue as it raises guidance following Q1 growth | 1 | Seeking Alpha | ||
| 13.05. | SHOULDER INNOVATIONS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.05. | SHOULDER INNOVATIONS, INC. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDLINE | 28,000 | 0,00 % | Jim Cramer Names Medline (MDLN) a Sleeper Compounder | ||
| OMADA HEALTH | 18,200 | +0,55 % | Omada Health, Inc.: Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day | ||
| ADVANCED BIOMED | 7,980 | -2,56 % | Morning Market Movers: InMed Pharmaceuticals, INLIF Limited, China SXT Pharmaceuticals, Advanced Biomed See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| CUPRINA HOLDINGS | 3,150 | -0,94 % | Cuprina Holdings LTD - F-1/A, Registration statement for certain foreign private issuers | ||
| MINIMED GROUP | 19,412 | +0,11 % | MiniMed Group, Inc. - 10-Q, Quarterly Report | ||
| CARLSMED | 12,600 | -0,79 % | Carlsmed, Inc. Announces Chief Operating Officer Appointment | CARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions... ► Artikel lesen | |
| PARK DENTAL PARTNERS | 18,400 | +2,79 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| TENON MEDICAL | 5,850 | -1,35 % | Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338 | LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain... ► Artikel lesen | |
| FRESENIUS | 45,040 | +0,75 % | Fresenius schießt an die DAX-Spitze: Das steckt hinter dem Kurssprung | Die Fresenius-Aktie setzt sich am 8. September 2026 mit einem deutlichen Kurssprung an die Spitze des DAX. Das Papier gewinnt zeitweise rund 4,4 % und steigt auf etwa 45,20 Euro, während der deutsche... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,230 | -0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,440 | -0,13 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 27,350 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| BRIGHTSPRING HEALTH SERVICES | 58,73 | 0,00 % | BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell? | ||
| LIFESTANCE HEALTH GROUP | 12,975 | +0,04 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 49,850 | -0,06 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen |
Das Unternehmen SHOULDER INNOVATIONS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -2,41 % bei einem Aktienkurs von 16,200 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHOULDER INNOVATIONS INC finden Sie auf Wallstreet Online.